The treatment of latent TB with 3HP is an important issue for the prevention of active TB. However, significant proportion of subjects receiving 3HP had adverse reaction. The main purpose of this observation study is to identify subjects who have higher risk to develop adverse reaction. Clinical characteristics and biomarker will be used to predict adverse reaction.
Study Type
OBSERVATIONAL
Enrollment
500
all patients taking 3HP under directly observed preventive therapy (DOPT) program
Institutional Review Board Chang Gung Medical Foundation
Taipei, Taiwan
RECRUITINGsTREM1 between >= grade 2 adverse reaction (SAR group) and< grade 2 adverse reaction (Non-SAR group)
Time frame: Change from Baseline sTREM1 at 2 weeks
sTREM1 between >= grade 2 adverse reaction (SAR group) and< grade 2 adverse reaction (Non-SAR group)
Time frame: Change from Baseline sTREM1 at SARs
sTREM2 between >= grade 2 adverse reaction (SAR group) and< grade 2 adverse reaction (Non-SAR group)
Time frame: Change from Baseline sTREM1 at 2 weeks
sTREM2 between >= grade 2 adverse reaction (SAR group) and< grade 2 adverse reaction (Non-SAR group)
Time frame: Change from Baseline sTREM1 at SARs
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.